Cargando…
Corrigendum: Involvement of insulin receptor substrates in cognitive impairment and Alzheimer’s disease
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034287/ https://www.ncbi.nlm.nih.gov/pubmed/31823898 http://dx.doi.org/10.4103/1673-5374.270163 |
Ejemplares similares
-
Involvement of insulin receptor substrates in cognitive impairment and Alzheimer’s disease
por: Tanokashira, Daisuke, et al.
Publicado: (2019) -
Corrigendum: Anodal transcranial direct current stimulation alleviates cognitive impairment in an APP/PS1 model of Alzheimer’s disease in the preclinical stage
Publicado: (2023) -
Corrigendum to “MUTYH Actively Contributes to Microglial Activation and Impaired Neurogenesis in the Pathogenesis of Alzheimer's Disease”
por: Mizuno, Yuri, et al.
Publicado: (2023) -
Effects of Creative Expression Therapy for Older Adults with Mild Cognitive Impairment at Risk of Alzheimer’s Disease: A Randomized Controlled Clinical Trial [Corrigendum]
Publicado: (2023) -
Epigenetic mechanisms in Alzheimer’s disease [Corrigendum]
Publicado: (2014)